Structure and Biochemical Properties of Human IgG

Human IgG is a glycoprotein belonging to the immunoglobulin superfamily. Its canonical structure comprises two identical heavy chains (γ chains) and two identical light chains (either κ or λ), linked by disulfide bonds to form a Y-shaped tetrameric molecule with an approximate molecular weight of 150 kDa.

The molecule is functionally divided into two antigen-binding fragments (Fab) and one crystallisable fragment (Fc). The Fab regions confer antigen specificity, while the Fc region mediates effector functions including Fc receptor engagement, complement fixation, and neonatal FcRn-mediated recycling—the latter being responsible for IgG's characteristically long serum half-life of approximately 21 days (IgG1, IgG2, IgG4) or approximately 7 days (IgG3).

Human IgG is a glycoprotein; N-linked glycosylation at Asn-297 within the CH2 domain of the Fc region is essential for Fc receptor binding and complement activation. The four subclasses (IgG1–IgG4) differ primarily in their hinge region length, number of inter-heavy-chain disulfide bonds, and capacity to activate complement and engage Fcγ receptors.

Quality Specifications and Certificate of Analysis

Research-grade Human IgG supplied by Aladdin Scientific is characterized lot-by-lot, with the exact protein concentration confirmed and reported on the Certificate of Analysis (COA) accompanying each shipment. Researchers should always consult the COA for the specific lot received before use.

For select lots (P230001659, P240013530, P240015375, P250016160, and P250016867), the confirmed concentration is 16.8 mg/mL. Typical quality attributes evaluated for research-grade Human IgG include:

• Protein concentration: Determined by UV absorbance (A280) or BCA/Bradford assay; lot-specific value stated on COA.
• Purity: Assessed by SDS-PAGE under reducing and non-reducing conditions; high-purity preparations show predominant bands at approximately 50 kDa (heavy chain) and 25 kDa (light chain) under reducing conditions.
• Sterility and endotoxin: Where specified, endotoxin levels are determined by LAL assay; verify requirements for your specific application on the COA.
• Biological activity: Fc receptor binding activity or ELISA reactivity may be confirmed depending on intended use.

Always store Human IgG according to the COA instructions. Generally, short-term storage at 2–8 °C is acceptable; for long-term storage, aliquot and store at −20 °C or −80 °C to avoid repeated freeze-thaw cycles that can reduce protein integrity.

Laboratory Protocols and Recommended Handling

The following guidelines apply to the preparation, dilution, and use of Human IgG in common research applications. Always wear appropriate personal protective equipment (PPE) and follow your institution's biosafety guidelines when handling human-derived proteins.

Reconstitution and Dilution

If supplied lyophilised, reconstitute Human IgG in the volume of ultrapure water or buffer (e.g., PBS pH 7.4) indicated on the COA to achieve the stated concentration. Allow the vial to equilibrate to room temperature before reconstitution. Gently mix by inversion or slow pipetting; avoid vortexing, which can cause aggregation and denaturation.

For liquid formulations (e.g., 16.8 mg/mL lots), thaw at 2–8 °C overnight or at room temperature for no more than 30 minutes. Centrifuge briefly (e.g., 300 × g, 5 min) to collect any condensate, then mix gently before use.

Use as an Isotype Control

Human IgG is widely used as a negative isotype control in flow cytometry, ELISA, and immunohistochemistry to assess non-specific background binding. Match the isotype control to the primary antibody in terms of species, isotype (IgG1, IgG2, IgG3, or IgG4), and concentration. Use the same incubation conditions (time, temperature, blocking buffer) as for the primary antibody.

Use as an ELISA Standard

Prepare a serial dilution series from a known stock concentration to generate a standard curve. Use a consistent diluent matrix that closely matches the sample matrix to minimise matrix effects. Confirm the stock concentration from the COA before calculating working concentrations.

Common Applications of Human IgG in Research

Human IgG is an exceptionally versatile reagent employed across a broad spectrum of immunological and biochemical research applications:

• Isotype control antibody: Minimises false-positive results in antibody-based assays by accounting for non-specific Fc receptor binding and non-immune background.
• ELISA standard and calibrator: Enables accurate quantification of IgG concentrations in patient or experimental samples via interpolation from a standard curve.
• Western blot control: Used to confirm antibody detection sensitivity and verify anti-human IgG secondary antibody performance.
• Fc receptor binding and blocking studies: Assesses Fc receptor (FcγRI, FcγRII, FcγRIII) affinity and specificity; used to block Fc receptors on cells prior to immunostaining to reduce background.
• Complement activation assays: IgG immune complexes can activate the classical complement pathway; Human IgG is used to model and study complement-dependent cytotoxicity (CDC).
• Antibody engineering and validation: Serves as a benchmark comparator molecule for evaluating engineered antibody variants, biosimilars, or novel therapeutic candidates.
• Drug delivery and pharmacokinetic modelling: Used in FcRn binding assays to study IgG half-life extension strategies relevant to therapeutic antibody development.

Troubleshooting and Frequently Encountered Issues

Researchers working with Human IgG may encounter the following technical issues. The guidance below is based on general best practices for immunoglobulin handling.